Medtronic plc (NYSE: MDT) announced its intent to acquire SPR Therapeutics, Inc. for approximately $650 million in cash, according to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE